Sort by
Refine Your Search
-
Listed
-
Category
-
Country
-
Field
-
The Bernhard Nocht Institute for Tropical Medicine (http://www.bnitm.de/en ) is the largest Research Institute for Tropical Medicine in Germany and is the National Reference Centre for Tropical
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed
-
the Faculty Board of Science and Technology, and be deemed to have the overall ability required to benefit from the education (Higher Education Ordinance, Chapter 7, Section 35). General entry requirements
-
established Systems Neuroimmunology Laboratory at LMU Munich (www.m-kaufmann.com ) is seeking a motivated and creative PhD candidate passionate about combining immunologic methods and advanced computational
-
DTU Tenure Track Researcher on Nanoreactors for Operando Visualizations of Nanoparticle Catalysis...
experience with TEM techniques including aberration-corrected high-resolution imaging, diffraction, ETEM, EFTEM and EELS. It is critical, that you have command of these TEM techniques under the lowest possible
-
on the evolution of gene regulatory networks and Wnt pathway functions in emerging model organisms (e. g. insects, annelids, snails, flatworms, cnidarians), utilizing ‘omics technologies and bioinformatics. Students
-
(stamped arrival date of the university central mail service or the time stamp on the email server of TUD applies), preferably via the TUD SecureMail Portal https://securemail.tu-dresden.de by sending it as
-
or neurological diseases? Driven to strengthen your scientific creativity and independent thinking? Up to 18 PhD positions are open in the international Marie S. Curie Doctoral Programme ‘Interdisciplinary Marie S
-
project’s principal investigator, Associate Professor Lars Rohwedder, an internationally recognized expert in the areas of approximation algorithms and parameterized algorithms, see https://larsrohwedder.com
-
data. We have developed in vivo single-cell CRISPR technologies to screen for dozens of molecular factors in vivo during developmental and disease. These technologies are a game-changer in the speed